Targacept: Phase II Trial Of Depression Drug Positive
Therapeutics Daily (subscription) (press release), PA - Nov 9, 2006Targacept, Inc. (TRGT) reported positive results from a double-blind, placebo-controlled Phase II clinical trial of mecamylamine ...
Source: www.therapeuticsdaily.com
Biovail to triple dividend, shed US sales force
Newark Star Ledger, USA - Dec 6, 2006... The stock rose 10 percent, even though Biovail said the likely introduction of generic versions of its Wellbutrin XL anti-depression drug would hit 2007 results ...
Source: www.nj.com
Ryan Delahoussaye from Blue October to Check into Habbo
Emediawire (press release), WA - Nov 30, 2006... The group's epic live shows and exploration of subjects like mental depression, drug use, love, betrayal, forgiveness and cathartic transcendence have helped ...
Source: www.emediawire.com
Biovail to review spending, ups outlook
Reuters Canada, Canada - Nov 9, 2006... it plans to review spending across most of its operations as it braces for the onslaught of generic versions of its key anti-depression drug Wellbutrin XL. ...
Source: ca.today.reuters.com
Targacept reports mixed depression drug data
Pharmaceutical Business Review - Nov 10, 2006By Victoria Harrison. A phase II trial of mecamylamine hydrochloride as an augmentation treatment for major depression has delivered ...
Source: www.pharmaceutical-business-review.com
Click here for more information about depression help depression help
